AKTX

Akari Therapeutics
AKTX

14 hedge funds and large institutions have $394K invested in Akari Therapeutics in 2024 Q4 according to their latest regulatory filings, with 5 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

more first-time investments, than exits

New positions opened: | Existing positions closed:

more funds holding

Funds holding: →

less ownership

Funds ownership: →

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

27% less capital invested

Capital invested by funds: $536K → $394K (-$142K)

Holders
14
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$178K
2
+$16K
3
+$12.2K
4
Renaissance Technologies
Renaissance Technologies
New York
+$6.58K
5
UBS Group
UBS Group
Switzerland
+$237

Top Sellers

1
-$99.1K
2
-$2
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$178K
2
$107K
3
$28.8K
4
$28.6K
5
$22.5K
6
$16K
7
$12.2K
8
$237
9
$183
10
$122
11
$61
12
$7
13
$6
14
$6
15
–